The natural history of aberrant crypt foci
Aberrant crypt foci (ACF) are the putative precursors to colorectal adenomas and may be useful as biomarkers. Knowledge of their natural history is essential to understanding their potential utility. Our purpose was to examine ACF detection 1 year after initial observation. We conducted a multicente...
Saved in:
Published in | Gastrointestinal endoscopy Vol. 67; no. 7; pp. 1097 - 1102 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York, NY
Mosby, Inc
01.06.2008
Elsevier |
Subjects | |
Online Access | Get full text |
ISSN | 0016-5107 1097-6779 1097-6779 |
DOI | 10.1016/j.gie.2007.08.048 |
Cover
Loading…
Abstract | Aberrant crypt foci (ACF) are the putative precursors to colorectal adenomas and may be useful as biomarkers. Knowledge of their natural history is essential to understanding their potential utility.
Our purpose was to examine ACF detection 1 year after initial observation.
We conducted a multicenter study of ACF by using a standardized protocol. ACF in the rectum were assessed and subjects returned 1 year later to evaluate the natural history of the lesions.
Ancillary study to the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Of 78 subjects enrolled, 64 (82%) returned for a repeat examination 1 year later. The mean age was 71 years, 70% were male, and 54% had a history of adenomatous polyps. At the initial examination, 66% of subjects had at least 1 ACF detected in the rectum, with a mean of 2.1 ± 2.3 per person. One year later, 60% of these subjects had at least 1 of the original ACF reidentified, but only 43% of all ACF were reidentified. A total of 56% of subjects had new ACF identified.
These results are generated from the pilot phase. Improvements or change in technique over time could have influenced the results.
A total of 60% of subjects who had ACF continued to have at least one ACF 1 year later, but less than half the specific ACF could be reidentified, and more than 50% of subjects had new ACF. These results imply a considerable dynamic to ACF detection over a 1-year period of observation. |
---|---|
AbstractList | Background Aberrant crypt foci (ACF) are the putative precursors to colorectal adenomas and may be useful as biomarkers. Knowledge of their natural history is essential to understanding their potential utility. Objective Our purpose was to examine ACF detection 1 year after initial observation. Design We conducted a multicenter study of ACF by using a standardized protocol. ACF in the rectum were assessed and subjects returned 1 year later to evaluate the natural history of the lesions. Setting Ancillary study to the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Results Of 78 subjects enrolled, 64 (82%) returned for a repeat examination 1 year later. The mean age was 71 years, 70% were male, and 54% had a history of adenomatous polyps. At the initial examination, 66% of subjects had at least 1 ACF detected in the rectum, with a mean of 2.1 ± 2.3 per person. One year later, 60% of these subjects had at least 1 of the original ACF reidentified, but only 43% of all ACF were reidentified. A total of 56% of subjects had new ACF identified. Limitations These results are generated from the pilot phase. Improvements or change in technique over time could have influenced the results. Conclusions A total of 60% of subjects who had ACF continued to have at least one ACF 1 year later, but less than half the specific ACF could be reidentified, and more than 50% of subjects had new ACF. These results imply a considerable dynamic to ACF detection over a 1-year period of observation. Aberrant crypt foci (ACF) are the putative precursors to colorectal adenomas and may be useful as biomarkers. Knowledge of their natural history is essential to understanding their potential utility. Our purpose was to examine ACF detection 1 year after initial observation. We conducted a multicenter study of ACF by using a standardized protocol. ACF in the rectum were assessed and subjects returned 1 year later to evaluate the natural history of the lesions. Ancillary study to the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Of 78 subjects enrolled, 64 (82%) returned for a repeat examination 1 year later. The mean age was 71 years, 70% were male, and 54% had a history of adenomatous polyps. At the initial examination, 66% of subjects had at least 1 ACF detected in the rectum, with a mean of 2.1 ± 2.3 per person. One year later, 60% of these subjects had at least 1 of the original ACF reidentified, but only 43% of all ACF were reidentified. A total of 56% of subjects had new ACF identified. These results are generated from the pilot phase. Improvements or change in technique over time could have influenced the results. A total of 60% of subjects who had ACF continued to have at least one ACF 1 year later, but less than half the specific ACF could be reidentified, and more than 50% of subjects had new ACF. These results imply a considerable dynamic to ACF detection over a 1-year period of observation. Aberrant crypt foci (ACF) are the putative precursors to colorectal adenomas and may be useful as biomarkers. Knowledge of their natural history is essential to understanding their potential utility.BACKGROUNDAberrant crypt foci (ACF) are the putative precursors to colorectal adenomas and may be useful as biomarkers. Knowledge of their natural history is essential to understanding their potential utility.Our purpose was to examine ACF detection 1 year after initial observation.OBJECTIVEOur purpose was to examine ACF detection 1 year after initial observation.We conducted a multicenter study of ACF by using a standardized protocol. ACF in the rectum were assessed and subjects returned 1 year later to evaluate the natural history of the lesions.DESIGNWe conducted a multicenter study of ACF by using a standardized protocol. ACF in the rectum were assessed and subjects returned 1 year later to evaluate the natural history of the lesions.Ancillary study to the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.SETTINGAncillary study to the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.Of 78 subjects enrolled, 64 (82%) returned for a repeat examination 1 year later. The mean age was 71 years, 70% were male, and 54% had a history of adenomatous polyps. At the initial examination, 66% of subjects had at least 1 ACF detected in the rectum, with a mean of 2.1 +/- 2.3 per person. One year later, 60% of these subjects had at least 1 of the original ACF reidentified, but only 43% of all ACF were reidentified. A total of 56% of subjects had new ACF identified.RESULTSOf 78 subjects enrolled, 64 (82%) returned for a repeat examination 1 year later. The mean age was 71 years, 70% were male, and 54% had a history of adenomatous polyps. At the initial examination, 66% of subjects had at least 1 ACF detected in the rectum, with a mean of 2.1 +/- 2.3 per person. One year later, 60% of these subjects had at least 1 of the original ACF reidentified, but only 43% of all ACF were reidentified. A total of 56% of subjects had new ACF identified.These results are generated from the pilot phase. Improvements or change in technique over time could have influenced the results.LIMITATIONSThese results are generated from the pilot phase. Improvements or change in technique over time could have influenced the results.A total of 60% of subjects who had ACF continued to have at least one ACF 1 year later, but less than half the specific ACF could be reidentified, and more than 50% of subjects had new ACF. These results imply a considerable dynamic to ACF detection over a 1-year period of observation.CONCLUSIONSA total of 60% of subjects who had ACF continued to have at least one ACF 1 year later, but less than half the specific ACF could be reidentified, and more than 50% of subjects had new ACF. These results imply a considerable dynamic to ACF detection over a 1-year period of observation. Aberrant crypt foci (ACF) are the putative precursors to colorectal adenomas and may be useful as biomarkers. Knowledge of their natural history is essential to understanding their potential utility. Our purpose was to examine ACF detection 1 year after initial observation. We conducted a multicenter study of ACF by using a standardized protocol. ACF in the rectum were assessed and subjects returned 1 year later to evaluate the natural history of the lesions. Ancillary study to the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Of 78 subjects enrolled, 64 (82%) returned for a repeat examination 1 year later. The mean age was 71 years, 70% were male, and 54% had a history of adenomatous polyps. At the initial examination, 66% of subjects had at least 1 ACF detected in the rectum, with a mean of 2.1 +/- 2.3 per person. One year later, 60% of these subjects had at least 1 of the original ACF reidentified, but only 43% of all ACF were reidentified. A total of 56% of subjects had new ACF identified. These results are generated from the pilot phase. Improvements or change in technique over time could have influenced the results. A total of 60% of subjects who had ACF continued to have at least one ACF 1 year later, but less than half the specific ACF could be reidentified, and more than 50% of subjects had new ACF. These results imply a considerable dynamic to ACF detection over a 1-year period of observation. |
Author | Schoen, Robert E. Pinsky, Paul Mutch, Matthew Seligson, David Umar, Asad Dry, Sarah M. Rall, Christopher |
Author_xml | – sequence: 1 givenname: Robert E. surname: Schoen fullname: Schoen, Robert E. – sequence: 2 givenname: Matthew surname: Mutch fullname: Mutch, Matthew – sequence: 3 givenname: Christopher surname: Rall fullname: Rall, Christopher – sequence: 4 givenname: Sarah M. surname: Dry fullname: Dry, Sarah M. – sequence: 5 givenname: David surname: Seligson fullname: Seligson, David – sequence: 6 givenname: Asad surname: Umar fullname: Umar, Asad – sequence: 7 givenname: Paul surname: Pinsky fullname: Pinsky, Paul |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20393872$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/18178205$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkkuLFDEUhYOMOD2jP8CN1EYXQrX3ph5JIQgy-IIBF47rkEpunLTVlTZJCf3vTdPtLAYcySKb75zknHsv2NkcZmLsOcIaAfs3m_UPT2sOINYg19DKR2yFMIi6F2I4YysoUN0hiHN2kdIGACRv8Ak7R4lCcuhW7PXNLVWzzkvUU3XrUw5xXwVX6ZFi1HOuTNzvcuWC8U_ZY6enRM9O9yX7_vHDzdXn-vrrpy9X769r08o-16hdL7G1fWubEbvRaIBWNMJy1LK1UnaNdSRahx1i30lqjcXGDbob7OhwaC7Zq6PvLoZfC6Wstj4ZmiY9U1iSEthz4J0s4IsTuIxbsmoX_VbHvfqbrgAvT4BORk-uBDI-3XEcmqGRghdOHDkTQ0qRnDI-6-zDnKP2k0JQh77VRpW-1aFvBVKVvosS7ynvPvGA5u1RQ6XE356iSsbTbMj6SCYrG_yD6nf31Gbysy_xftKe0iYscS7TUagSV6C-HXbgsALl8L4b2mIw_NvgP4__ARQ_vUA |
CODEN | GAENBQ |
CitedBy_id | crossref_primary_10_1158_1940_6207_CAPR_09_0257 crossref_primary_10_1016_j_gie_2007_10_038 crossref_primary_10_1016_j_gtc_2013_05_002 crossref_primary_10_14309_ctg_0000000000000047 crossref_primary_10_1016_j_cbi_2012_01_008 crossref_primary_10_1016_j_gie_2008_12_060 crossref_primary_10_3390_medicina58121767 crossref_primary_10_3390_antiox11122368 crossref_primary_10_1007_s10552_018_1039_7 crossref_primary_10_3109_00365521_2014_951390 crossref_primary_10_1016_j_bpg_2010_04_005 crossref_primary_10_1093_toxres_tfac049 crossref_primary_10_1016_j_bpg_2010_08_002 crossref_primary_10_1158_1940_6207_CAPR_10_0215 crossref_primary_10_1016_j_cgh_2009_01_016 crossref_primary_10_1007_s10552_008_9278_7 crossref_primary_10_1097_MOG_0b013e32831db286 crossref_primary_10_1111_j_1463_1318_2011_02925_x crossref_primary_10_1007_s00292_012_1640_6 crossref_primary_10_1016_S1077_9108_08_79019_4 crossref_primary_10_1038_ajg_2010_109 crossref_primary_10_1158_1940_6207_CAPR_19_0316 crossref_primary_10_1016_j_gie_2008_07_052 crossref_primary_10_1586_14737159_9_2_125 crossref_primary_10_4253_wjge_v4_i12_561 crossref_primary_10_1080_15287394_2024_2431921 |
Cites_doi | 10.1016/S0197-2456(00)00098-2 10.1016/j.cgh.2007.02.014 10.1111/j.1572-0241.2006.00578.x 10.1177/019262339902700604 10.1207/S15327914NC431_1 10.1016/S0016-5107(97)70212-8 10.1016/0016-5085(95)90071-3 10.1056/NEJM199810293391803 10.1016/S0016-5107(02)70113-2 10.1093/jnci/dji175 10.1111/j.1572-0241.2005.40891.x |
ContentType | Journal Article |
Copyright | 2008 American Society for Gastrointestinal Endoscopy American Society for Gastrointestinal Endoscopy 2008 INIST-CNRS |
Copyright_xml | – notice: 2008 American Society for Gastrointestinal Endoscopy – notice: American Society for Gastrointestinal Endoscopy – notice: 2008 INIST-CNRS |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.gie.2007.08.048 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1097-6779 |
EndPage | 1102 |
ExternalDocumentID | 18178205 20393872 10_1016_j_gie_2007_08_048 S0016510707026594 1_s2_0_S0016510707026594 |
Genre | Randomized Controlled Trial Multicenter Study Journal Article |
GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQQT AAQXK AATTM AAWTL AAXKI AAXUO AAYWO ABBQC ABFNM ABFRF ABJNI ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADVLN AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 EX3 F5P FD8 FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDZ HMK HMO HVGLF HZ~ IHE J1W K-O KOM L7B LZ1 M28 M41 MO0 N4W N9A O-L O9- OAUVE OC. ON0 OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SDF SDG SEL SES SEW SJN SPCBC SSH SSZ T5K UNMZH UV1 WH7 WOW X7M Z5R ZGI ZXP ~G- AACTN AFCTW AFKWA AJOXV AMFUW RIG AAIAV AAYXX AGRNS CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 EFLBG |
ID | FETCH-LOGICAL-c486t-1af6814d64d3b15bca004737d21a84d8853dfe74f1511658e4cd13f9a59dbf193 |
IEDL.DBID | .~1 |
ISSN | 0016-5107 1097-6779 |
IngestDate | Fri Sep 05 07:40:26 EDT 2025 Thu Apr 03 06:56:05 EDT 2025 Mon Jul 21 09:10:38 EDT 2025 Thu Apr 24 23:11:53 EDT 2025 Tue Jul 01 02:17:36 EDT 2025 Mon Jul 22 05:35:05 EDT 2024 Sun Feb 23 10:18:43 EST 2025 Tue Aug 26 16:32:53 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | ACF PLCO FSG aberrant crypt foci Prostate, Lung, Colorectal, and Ovarian cancer screening trial flexible sigmoidoscopy Colonic disease Digestive diseases Intestinal disease Colon premalignant lesion Premalignant lesion |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c486t-1af6814d64d3b15bca004737d21a84d8853dfe74f1511658e4cd13f9a59dbf193 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
PMID | 18178205 |
PQID | 71620258 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_71620258 pubmed_primary_18178205 pascalfrancis_primary_20393872 crossref_citationtrail_10_1016_j_gie_2007_08_048 crossref_primary_10_1016_j_gie_2007_08_048 elsevier_sciencedirect_doi_10_1016_j_gie_2007_08_048 elsevier_clinicalkeyesjournals_1_s2_0_S0016510707026594 elsevier_clinicalkey_doi_10_1016_j_gie_2007_08_048 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2008-06-01 |
PublicationDateYYYYMMDD | 2008-06-01 |
PublicationDate_xml | – month: 06 year: 2008 text: 2008-06-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | New York, NY |
PublicationPlace_xml | – name: New York, NY – name: United States |
PublicationTitle | Gastrointestinal endoscopy |
PublicationTitleAlternate | Gastrointest Endosc |
PublicationYear | 2008 |
Publisher | Mosby, Inc Elsevier |
Publisher_xml | – name: Mosby, Inc – name: Elsevier |
References | Hurlstone, Karajeh, Sanders (bib9) 2005; 100 Seike, Koda, Oda (bib13) 2006; 101 Pretlow, Barrow, Ashton (bib3) 1991; 51 Adler, Gostout, Sorbi (bib8) 2002; 56 Takayama, Katsuki, Takahashi (bib7) 1998; 339 Gupta, Pretlow, Schoen (bib10) 2007; 5 Weissfeld, Schoen, Pinsky (bib11) 2005; 97 Fenoglio-Preiser, Noffsinger (bib1) 1999; 27 Yokota, Sugano, Kondo (bib4) 1997; 46 Corpet, Tache (bib2) 2002; 43 Yamashita, Minamoto, Ochiai (bib5) 1995; 108 Siu, Robinson, Schwartz (bib6) 1999; 59 Prorok, Andriole, Bresalier (bib12) 2000; 21 Yamashita (10.1016/j.gie.2007.08.048_bib5) 1995; 108 Siu (10.1016/j.gie.2007.08.048_bib6) 1999; 59 Weissfeld (10.1016/j.gie.2007.08.048_bib11) 2005; 97 Yokota (10.1016/j.gie.2007.08.048_bib4) 1997; 46 Takayama (10.1016/j.gie.2007.08.048_bib7) 1998; 339 Adler (10.1016/j.gie.2007.08.048_bib8) 2002; 56 Seike (10.1016/j.gie.2007.08.048_bib13) 2006; 101 Hurlstone (10.1016/j.gie.2007.08.048_bib9) 2005; 100 Prorok (10.1016/j.gie.2007.08.048_bib12) 2000; 21 Gupta (10.1016/j.gie.2007.08.048_bib10) 2007; 5 Corpet (10.1016/j.gie.2007.08.048_bib2) 2002; 43 Pretlow (10.1016/j.gie.2007.08.048_bib3) 1991; 51 Fenoglio-Preiser (10.1016/j.gie.2007.08.048_bib1) 1999; 27 18513552 - Gastrointest Endosc. 2008 Jun;67(7):1103-5 |
References_xml | – volume: 339 start-page: 1277 year: 1998 end-page: 1284 ident: bib7 article-title: Aberrant crypt foci of the colon as precursors of adenoma and cancer publication-title: N Engl J Med – volume: 59 start-page: 63 year: 1999 end-page: 66 ident: bib6 article-title: The identification of monoclonality in human aberrant crypt foci publication-title: Cancer Res – volume: 27 start-page: 632 year: 1999 end-page: 642 ident: bib1 article-title: Aberrant crypt foci: a review publication-title: Toxicol Pathol – volume: 46 start-page: 61 year: 1997 end-page: 65 ident: bib4 article-title: Detection of aberrant crypt foci by magnifying colonoscopy publication-title: Gastrointest Endosc – volume: 5 start-page: 526 year: 2007 end-page: 533 ident: bib10 article-title: Aberrant crypt foci: what we know and what we need to know publication-title: Clin Gastroenterol Hepatol – volume: 21 start-page: 273S year: 2000 end-page: 309S ident: bib12 article-title: Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial publication-title: Control Clin Trials – volume: 97 start-page: 989 year: 2005 end-page: 997 ident: bib11 article-title: Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial publication-title: JNatl Cancer Inst – volume: 43 start-page: 1 year: 2002 end-page: 21 ident: bib2 article-title: Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency publication-title: Nutri Cancer – volume: 51 start-page: 1564 year: 1991 end-page: 1567 ident: bib3 article-title: Aberrant crypts: putative preneoplastic foci in human colonic mucosa publication-title: Cancer Res – volume: 108 start-page: 434 year: 1995 end-page: 440 ident: bib5 article-title: Frequent and characteristic K- publication-title: Gastroenterology – volume: 101 start-page: 1362 year: 2006 end-page: 1369 ident: bib13 article-title: Assessment of rectal aberrant crypt foci by standard chromoscopy and its predictive value for colonic advanced neoplasms publication-title: Am J Gastroenterol – volume: 100 start-page: 1283 year: 2005 end-page: 1289 ident: bib9 article-title: Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia publication-title: Am J Gastroenterol – volume: 56 start-page: 657 year: 2002 end-page: 662 ident: bib8 article-title: Endoscopic identification and quantification of aberrant crypt foci in the human colon publication-title: Gastrointest Endosc – volume: 21 start-page: 273S issue: 6 Suppl year: 2000 ident: 10.1016/j.gie.2007.08.048_bib12 article-title: Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial publication-title: Control Clin Trials doi: 10.1016/S0197-2456(00)00098-2 – volume: 5 start-page: 526 year: 2007 ident: 10.1016/j.gie.2007.08.048_bib10 article-title: Aberrant crypt foci: what we know and what we need to know publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2007.02.014 – volume: 101 start-page: 1362 year: 2006 ident: 10.1016/j.gie.2007.08.048_bib13 article-title: Assessment of rectal aberrant crypt foci by standard chromoscopy and its predictive value for colonic advanced neoplasms publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.2006.00578.x – volume: 27 start-page: 632 year: 1999 ident: 10.1016/j.gie.2007.08.048_bib1 article-title: Aberrant crypt foci: a review publication-title: Toxicol Pathol doi: 10.1177/019262339902700604 – volume: 43 start-page: 1 year: 2002 ident: 10.1016/j.gie.2007.08.048_bib2 article-title: Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency publication-title: Nutri Cancer doi: 10.1207/S15327914NC431_1 – volume: 46 start-page: 61 year: 1997 ident: 10.1016/j.gie.2007.08.048_bib4 article-title: Detection of aberrant crypt foci by magnifying colonoscopy publication-title: Gastrointest Endosc doi: 10.1016/S0016-5107(97)70212-8 – volume: 108 start-page: 434 year: 1995 ident: 10.1016/j.gie.2007.08.048_bib5 article-title: Frequent and characteristic K-ras activation and absence of p53 protein accumulation in aberrant crypt foci of the colon publication-title: Gastroenterology doi: 10.1016/0016-5085(95)90071-3 – volume: 59 start-page: 63 year: 1999 ident: 10.1016/j.gie.2007.08.048_bib6 article-title: The identification of monoclonality in human aberrant crypt foci publication-title: Cancer Res – volume: 51 start-page: 1564 year: 1991 ident: 10.1016/j.gie.2007.08.048_bib3 article-title: Aberrant crypts: putative preneoplastic foci in human colonic mucosa publication-title: Cancer Res – volume: 339 start-page: 1277 year: 1998 ident: 10.1016/j.gie.2007.08.048_bib7 article-title: Aberrant crypt foci of the colon as precursors of adenoma and cancer publication-title: N Engl J Med doi: 10.1056/NEJM199810293391803 – volume: 56 start-page: 657 year: 2002 ident: 10.1016/j.gie.2007.08.048_bib8 article-title: Endoscopic identification and quantification of aberrant crypt foci in the human colon publication-title: Gastrointest Endosc doi: 10.1016/S0016-5107(02)70113-2 – volume: 97 start-page: 989 year: 2005 ident: 10.1016/j.gie.2007.08.048_bib11 article-title: Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial publication-title: JNatl Cancer Inst doi: 10.1093/jnci/dji175 – volume: 100 start-page: 1283 year: 2005 ident: 10.1016/j.gie.2007.08.048_bib9 article-title: Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.2005.40891.x – reference: 18513552 - Gastrointest Endosc. 2008 Jun;67(7):1103-5 |
SSID | ssj0008231 |
Score | 2.0467622 |
Snippet | Aberrant crypt foci (ACF) are the putative precursors to colorectal adenomas and may be useful as biomarkers. Knowledge of their natural history is essential... Background Aberrant crypt foci (ACF) are the putative precursors to colorectal adenomas and may be useful as biomarkers. Knowledge of their natural history is... |
SourceID | proquest pubmed pascalfrancis crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1097 |
SubjectTerms | Adenoma - diagnosis Adenoma - pathology Aged Aged, 80 and over Biological and medical sciences Biopsy, Needle - methods Biopsy, Needle - statistics & numerical data Cell Transformation, Neoplastic - pathology Colonic Polyps - pathology Colonoscopy - methods Colorectal Neoplasms - diagnosis Colorectal Neoplasms - pathology Digestive system. Abdomen Endoscopy Endoscopy, Gastrointestinal - methods Female Follow-Up Studies Gastroenterology and Hepatology Gastroenterology. Liver. Pancreas. Abdomen Humans Immunohistochemistry Intestinal Mucosa - pathology Investigative techniques, diagnostic techniques (general aspects) Male Medical sciences Middle Aged Monitoring, Physiologic - methods Precancerous Conditions - diagnosis Precancerous Conditions - pathology Sensitivity and Specificity Sigmoidoscopy - methods Stomach. Duodenum. Small intestine. Colon. Rectum. Anus Time Factors Tumors |
Title | The natural history of aberrant crypt foci |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0016510707026594 https://www.clinicalkey.es/playcontent/1-s2.0-S0016510707026594 https://dx.doi.org/10.1016/j.gie.2007.08.048 https://www.ncbi.nlm.nih.gov/pubmed/18178205 https://www.proquest.com/docview/71620258 |
Volume | 67 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS9xAEB9EoQilaFvr-XHNQ5-E6CXZ7G4eRZTTok8VfFv2U66Uu-MSH3zp3-5MsjkRv0Dyluwkm8nszGRn5jcAv3ipucArKedVSJkTNq1KL9NgeFnYymupaUP_8oqPr9nFTXmzAid9LQylVUbd3-n0VlvHM0eRm0fzyYRqfDOOEiXwyHlZESYoY4Lw8w__P6Z5UJir08Y8pdF9ZLPN8bqd-IhiKA9H1ALoZdv0ea5r5FjoWl287ou2NulsA75EZzI57ua7CSt--hU-XcZw-Tc4QCFIWuhOHNUhC98ns5Bo4xf4lCaxi_t5kwT8QN_h-uz0z8k4jc0RUsskb9JMBy4z5jhzhclKYzUBPxbC5ZmWzEk0wy54wQKadOST9My6rAiVLitnArptW7A6nU39NiR2pKXFX2FDaPM507pAL84bIwgqMXfFAEY9W5SNyOHUwOKf6lPE_irkJHW0FIqaWjI5gIMlybyDzXhrcN7zWvX1oKjBFCr1t4jES0S-jmuwVpmqczVSz-RkAGxJ-UTU3nvg8IkYLN8rp_JmKfIB_OzlQuEapcCLnvrZXa0IpQt9S7zFj05cHnkiMwIsLHc-NqddWO_yV2hXaA9Wm8Wd30cnqTHDdhUMYe34_Pf46gHYSwzk |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9xADLYoldpKqOqbpS3k0BNSYJPMK0eEirYtywkkbqN5VltVu6tNOHDpb8dOJosQlEpVbsk4mTge2xnbnwG-CG6ExCu5EHXMmZcur3lQebSCV64ORhna0J-eickF-37JLzfgeKiFobTKpPt7nd5p63TmMHHzcDmbUY1vIVCiJB6l4DV7Ak8ZrySJ9sGf2zwPinP16ljkNHwIbXZJXj9nIcEYqoMx9QB62DhtLU2DLIt9r4u_O6OdUTp5BS-TN5kd9RN-DRth_gaeTVO8_C3soxRkHXYnjuqhha-zRcyMDSt8Spu51fWyzSJ-oXdwcfL1_HiSp-4IuWNKtHlholAF84L5yhbcOkPIj5X0ZWEU8wrtsI9Bsog2HRmlAnO-qGJteO1tRL_tPWzOF_OwDZkbG-XwX9gS3HzJjKnQjQvWSsJKLH01gvHAFu0SdDh1sPithxyxXxo5SS0tpaaulkyNYH9NsuxxMx4bXA681kNBKKowjVr9MSL5EFFo0iJsdKGbUo_1PUEZAVtT3pG1fz1w944YrN-rpPpmJcsR7A1yoXGRUuTFzMPiqtEE04XOJd7iQy8utzxRBSEW8p3_m9MePJ-cT0_16bezHx_hRZ_MQltEn2CzXV2Fz-gxtXa3WxE3-VYOeg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+natural+history+of+aberrant+crypt+foci&rft.jtitle=Gastrointestinal+endoscopy&rft.au=SCHOEN%2C+Robert+E&rft.au=MUTCH%2C+Matthew&rft.au=RALL%2C+Christopher&rft.au=DRY%2C+Sarah+M&rft.date=2008-06-01&rft.pub=Elsevier&rft.issn=0016-5107&rft.volume=67&rft.issue=7&rft.spage=1097&rft.epage=1102&rft_id=info:doi/10.1016%2Fj.gie.2007.08.048&rft.externalDBID=n%2Fa&rft.externalDocID=20393872 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00165107%2FS0016510708X00069%2Fcov150h.gif |